Fluoromycobacteriophages can detect viable Mycobacterium tuberculosis and determine phenotypic rifampicin resistance in 3-5 days from sputum collection

The World Health Organization (WHO) estimates that 40% of tuberculosis (TB) cases are not diagnosed and treated correctly. Even though there are several diagnostic tests available in the market, rapid, easy, inexpensive detection, and drug susceptibility testing (DST) of Mycobacterium tuberculosis i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rondón, L., Urdániz, E., Latini, C., Payaslian, F., Matteo, M., Sosa, E.J., Do Porto, D.F., Turjanski, A.G., Nemirovsky, S., Hatfull, G.F., Poggi, S., Piuri, M.
Formato: JOUR
Materias:
Diagnosis
Drug susceptibility testing
Fluoromycobacteriophages
MCherrybombΦ
Tuberculosis
amikacin
ethambutol
isoniazid
kanamycin
ofloxacin
rifampicin
streptomycin
acid fast bacterium
adult
antibiotic resistance
antibiotic sensitivity
antibiotic therapy
Article
atypical Mycobacterium
bacterium culture
bioinformatics
clinical protocol
comparative study
diagnostic test accuracy study
DNA isolation
drug sensitivity
female
fluorescence microscopy
fluoromycobacteriophage
human
male
microbiological examination
middle income country
mycobacteriophage
Mycobacterium tuberculosis
next generation sequencing
patient monitoring
phenotype
predictive value
sensitivity and specificity
sputum analysis
transgender
treatment response
tuberculosis
whole genome sequencing
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_1664302X_v9_nJUL_p_Rondon
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares